Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion type Assertion NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_head.
- NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion description "[Treatment failure with drug-resistant virus is particularly interesting because it tends to be rare, with lack of sensitivity usually associated with the presence of CXCR4-using virus (CXCR4 is the main alternative coreceptor HIV-1 uses, in addition to CD4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_provenance.
- NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion evidence source_evidence_literature NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_provenance.
- NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion SIO_000772 26339063 NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_provenance.
- NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion wasDerivedFrom befree-2016 NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_provenance.
- NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_assertion wasGeneratedBy ECO_0000203 NP1293690.RAeX2T_UM20RrrMOssKz_FnejryU7eob35ICO3R-WCLU4130_provenance.